Alexander Pearson to Receptor, Fibroblast Growth Factor, Type 1
This is a "connection" page, showing publications Alexander Pearson has written about Receptor, Fibroblast Growth Factor, Type 1.
Connection Strength
0.044
-
Lucitanib for the Treatment of HR+/HER2- Metastatic Breast Cancer: Results from the Multicohort Phase II FINESSE Study. Clin Cancer Res. 2020 01 15; 26(2):354-363.
Score: 0.044